Cramer Rosenthal McGlynn’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.1M Buy
303,431
+53,869
+22% +$2.26M 0.74% 53
2025
Q4
$11.3M Buy
249,562
+98,194
+65% +$3.59M 0.73% 48
2025
Q3
$4.61M Sell
151,368
-1,657
-1% -$50.9K 0.29% 84
2025
Q2
$4.5M Sell
153,025
-67,251
-31% -$2.01M 0.31% 76
2025
Q1
$7.7M Buy
220,276
+47,245
+27% +$1.87M 0.55% 61
2024
Q4
$7.7M Buy
+173,031
New +$7.77M 0.44% 73
2019
Q2
Sell
-303,811
Closed -$24.6M 128
2019
Q1
$24.6M Sell
303,811
-2,481
-0.8% -$186K 0.59% 71
2018
Q4
$18.8M Sell
306,292
-266,617
-47% -$18.1M 0.47% 74
2018
Q3
$41.2M Sell
572,909
-621,443
-52% -$39.1M 0.79% 59
2018
Q2
$62.6M Sell
1,194,352
-258,806
-18% -$12.2M 1.12% 33
2018
Q1
$63.1M Buy
1,453,158
+1,150,108
+380% +$52.9M 1.03% 32
2017
Q4
$14.7M Sell
303,050
-5,990
-2% -$302K 0.24% 123
2017
Q3
$15.8M Sell
309,040
-56,040
-15% -$2.68M 0.25% 122
2017
Q2
$15.7M Sell
365,080
-19,484
-5% -$809K 0.24% 124
2017
Q1
$15.6M Sell
384,564
-81,100
-17% -$2.99M 0.24% 131
2016
Q4
$15.8M Sell
465,664
-58,780
-11% -$2.02M 0.23% 130
2016
Q3
$20.1M Sell
524,444
-37,666
-7% -$1.4M 0.31% 110
2016
Q2
$19.2M Buy
+562,110
New +$17.5M 0.31% 115

Other funds holding OMCL

Cramer Rosenthal McGlynn's OMCL Position: Q1 2026 in Review

Cramer Rosenthal McGlynn increased its Omnicell (OMCL) stake by 22% in Q1 2026, buying an estimated $2.26M and bringing the position to 303,431 shares worth $10.1M. The position accounts for 0.74% of the portfolio, ranked #53.

Cramer Rosenthal McGlynn first reported a position in OMCL in Q2 2016 and has held it in 18 quarters since. The position peaked at $63.1M in Q1 2018. 272 funds tracked by Wall St. Rank hold OMCL as of Q1 2026.

  • Cramer Rosenthal McGlynn held 303,431 shares of Omnicell worth $10.1M as of Q1 2026.
  • Cramer Rosenthal McGlynn bought 53,869 Omnicell shares in Q1 2026, an estimated $2.26M.
  • Omnicell made up 0.74% of Cramer Rosenthal McGlynn's portfolio in Q1 2026, its #53 holding.
  • Cramer Rosenthal McGlynn first reported a position in Omnicell in Q2 2016 and has held it in 18 quarters since.
  • Cramer Rosenthal McGlynn's Omnicell position peaked at $63.1M in Q1 2018.
  • 272 funds tracked by Wall St. Rank held Omnicell as of Q1 2026.

Based on Cramer Rosenthal McGlynn's 13F filing for Q1 2026, filed 15 May 2026.